Advancements and Clinical Applications Prospects of Epigenetic Biomarkers in Liquid Biopsy for Oral Squamous Cell Carcinoma
Current Issues in Molecular Biology · 01.07.2026 · 48 (7) · 680
DOI: 10.3390/cimb48070680 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 01.07.2026. Verfasst von Yuan Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Medicine, School of Stomatology, Capital Medical University, Beijing 100070, China. Die Arbeit nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Beijing Municipal Natural Science Foundation, The National Natural Science Foundation of China, The Young Scientist Program of Beijing Stomatological Hospital, Capital Medical University.
Abstract (Originalsprache)
Oral squamous-cell carcinoma (OSCC) is a prevalent malignancy of the head and neck region. A delay in the diagnosis of OSCC often results in a high metastatic tendency, which is the main reason for the high patient mortality. Dynamic monitoring and management of the onset and progression of OSCC are critical for improving patient survival rates. Liquid biopsy technology—characterized by its non-invasive nature, procedural convenience, and capacity for longitudinal monitoring—is a promising adjunct to histopathological examination for the early diagnosis of OSCC. Epigenetic alterations, characterized by reversibility and long-term stability in physiological fluids, are critical enablers of liquid biopsy and its clinical utility. Advances in detection technologies, including quantitative polymerase chain reaction (qPCR), digital droplet PCR (ddPCR), next-generation sequencing (NGS), and electrochemical biosensors, have significantly facilitated the research and clinical translation of epigenetic biomarkers in oral liquid biopsies. However, translating epigenetic biomarkers from research discovery to clinical practice for OSCC remains hindered by several critical challenges: the scarcity of large-scale, rigorously designed cohort studies, limited multicenter validation, inconsistent preprocessing protocols, and a lack of harmonized analytical platforms. Finally, we propose a conceptual framework to outline potential clinical application models for these biomarkers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral Medicine, School of Stomatology, Capital Medical University, Beijing 100070, China.
- Department of Oral and Maxillofacial Surgery, School of Stomatology, Capital Medical University, Beijing 100070, China.
Förderung
- The Beijing Municipal Natural Science Foundation
- The National Natural Science Foundation of China
- The Young Scientist Program of Beijing Stomatological Hospital, Capital Medical University
- The Beijing High-Level Innovation and Entrepreneurship Talent Support Program Young Backbone Talent Projects
- Innovation Fund Incubation Project of Beijing Stomatological Hospital, Capital Medical University
Zitieren
APA
Li, Y., Liu, Y., Cong, Y., Liu, J., Pan, W., Guan, X., & Wang, J. (2026). Advancements and Clinical Applications Prospects of Epigenetic Biomarkers in Liquid Biopsy for Oral Squamous Cell Carcinoma. Current Issues in Molecular Biology, 48(7), 680. https://doi.org/10.3390/cimb48070680
Vancouver
Li Y, Liu Y, Cong Y, Liu J, Pan W, Guan X, et al. Advancements and Clinical Applications Prospects of Epigenetic Biomarkers in Liquid Biopsy for Oral Squamous Cell Carcinoma. Current Issues in Molecular Biology. 2026;48(7):680. doi:10.3390/cimb48070680
BibTeX
@article{Li2026,
author = {Li, Yuan and Liu, Yao and Cong, Yuyi and Liu, Juan and Pan, Wen and Guan, Xiaobing and Wang, Jiaqi},
title = {Advancements and Clinical Applications Prospects of Epigenetic Biomarkers in Liquid Biopsy for Oral Squamous Cell Carcinoma},
journal = {Current Issues in Molecular Biology},
year = {2026},
volume = {48},
number = {7},
pages = {680},
doi = {10.3390/cimb48070680}
}
EUVIMED